The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Murine models of pulmonary fibrosis
Abstract
Human pulmonary fibrosis is characterized by alveolar epithelial cell injury, areas of type II cell hyperplasia, accumulation of fibroblasts and myofibroblasts, and the deposition of extracellular matrix proteins. The result is a progressive loss of normal lung architecture and impairment in gas exchange. Pertinent features of the human disease include temporal heterogeneity of the fibrotic lesions, progressive nature of the disease, development of fibrotic foci, and in some patients, a rapid worsening of symptoms known as an acute exacerbation. No current animal model recapitulates all of these cardinal manifestations of the human disease. However, investigations using murine models have led to the identification of many pathological cells and mediators that are believed to be important in human disease as well. In this review, we will summarize the characteristics, advantages, and disadvantages of many of the currently utilized murine models of pulmonary fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., & Cerami, A. (1994) · Molecular Medicine · doi:10.1007/bf03403533 · Cited by 1,308
Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Collard, H. R., Moore, B. B., Flaherty, K. R., Brown, K. K., Kaner, R. J., King, T. E., Lasky, J. A., Loyd, J. E., Noth, I., Olman, M. A., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-463pp · Cited by 1,130
Self-citationCirculating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
The epidemiology of interstitial lung diseases.
Coultas, D. B., Zumwalt, R. E., Black, W. C., & Sobonya, R. E. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.4.7921471 · Cited by 946
international consensus statement
Clements, R. V., & Simanowitz, A. (2000) · Cited by 852
Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., & Gauldie, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12568 · Cited by 753
The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis
Martinez, F. J., Safrin, S., Weycker, D., Starko, K. M., Bradford, W. Z., King, T. E., Flaherty, K. R., Schwartz, D. A., Noble, P. W., Raghu, G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_1-200506210-00005 · Cited by 622
Kuhn, C., Boldt, J., King, T. E., Crouch, E., Vartio, T., & McDonald, J. A. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.6.1693 · Cited by 466
Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse.
Szapiel, S. V., Elson, N., Fulmer, J. D., Hunninghake, G. W., & Crystal, R. G. (1979) · PubMed · doi:10.1164/arrd.1979.120.4.893 · Cited by 463
Time course of bleomycin‐induced lung fibrosis
Izbicki, G., Segel, M. J., Christensen, T. G., Conner, M. W., & Breuer, R. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00220.x · Cited by 447
CCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space after Fibrotic Injury
Moore, B. B., Kolodsick, J. E., Thannickal, V. J., Cooke, K., Moore, T. A., Hogaboam, C., Wilke, C. A., & Toews, G. B. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62289-4 · Cited by 441
Self-citationTransient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice
Nakao, A., Fujii, M., Matsumura, R., Kumano, K., Saito, Y., Miyazono, K., & Iwamoto, I. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6094 · Cited by 405
Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema
D'Armiento, J., Dalal, S. S., Okada, Y., Berg, R. A., & Chada, K. (1992) · Cell · doi:10.1016/0092-8674(92)90391-o · Cited by 379
Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling
Moore, B. B., Paine, R., Christensen, P. J., Moore, T. A., Sitterding, S., Ngan, R., Wilke, C. A., Kuziel, W. A., & Toews, G. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4368 · Cited by 371
Self-citationMiyazaki, Y., Araki, K., Vesin, C., Garcia, I., Kapanci, Y., Whitsett, J. A., Piguet, P. F., & Vassalli, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118029 · Cited by 370
Fibrosis of the Lung and Other Tissues: New Concepts in Pathogenesis and Treatment
Sime, P. J., & O'Reilly, K. M. A. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5008 · Cited by 330
The Role of CCL12 in the Recruitment of Fibrocytes and Lung Fibrosis
Moore, B. B., Murray, L., Das, A., Wilke, C. A., Herrygers, A. B., & Toews, G. B. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0239oc · Cited by 309
Self-citationBleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin.
Thrall, R. S., McCormick, J. R., Jack, R., McReynolds, R. A., & Ward, P. A. (1979) · PubMed Central · Cited by 303
A role for ferrous ion and oxygen in the degradation of DNA by bleomycin
Sausville, E. A., Peisach, J., & Horwitz, S. B. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(76)90882-2 · Cited by 290
Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis.
Adamson, I. Y. R., Young, L., & Bowden, D. H. (1988) · Europe PMC (PubMed Central) · Cited by 285
Rübe, C. E., Uthe, D., Schmid, K. W., Richter, K. D., Wessel, J., Schuck, A., Willich, N., & Rübe, C. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00482-x · Cited by 282
Bone Marrow Origin of Myofibroblasts in Irradiation Pulmonary Fibrosis
Epperly, M. W., Guo, H., Gretton, J. E., & Greenberger, J. S. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0069oc · Cited by 265
TGF-β and Smad3 Signaling Link Inflammation to Chronic Fibrogenesis
Bonniaud, P., Margetts, P. J., Ask, K., Flanders, K., Gauldie, J., & Kolb, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5390 · Cited by 252
The mechanism of the bleomycin-induced cleavage of DNA
William Lown, J., & Sim, S.-K. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(77)80099-5 · Cited by 248
Oberdörster, G. (1996) · PubMed · Cited by 229
Tang, W., Geba, G. P., Zheng, T., Ray, P., Homer, R. J., Kuhn, C., Flavell, R. A., & Elias, J. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119113 · Cited by 210
Prolonged Transgene Expression in Cotton Rat Lung with Recombinant Adenoviruses Defective in E2a
Engelhardt, J. F., Litzky, L., & Wilson, J. M. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.10-1217 · Cited by 208
Baran, C. P., Opalek, J. M., McMaken, S., Newland, C. A., O'Brien, J. M., Hunter, M. G., Bringardner, B. D., Monick, M. M., Brigstock, D. R., Stromberg, P. C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200609-1279oc · Cited by 196
A role for C-C chemokines in fibrotic lung disease
Smith, R. E., Stricter, R. M., Zhang, K., Phan, S. H., Standiford, T. J., Lukacs, N. W., & Kunkel, S. L. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.5.782 · Cited by 193
Korfhagen, T. R., Swantz, R. J., Wert, S. E., McCarty, J. M., Kerlakian, C. B., Glasser, S. W., & Whitsett, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117152 · Cited by 191
Umezawa, H., Ishizuka, M., Maeda, K., & Takeuchi, T. (1967) · Cancer · doi:10.1002/1097-0142(1967)20:5<891::aid-cncr2820200550>3.0.co;2-v · Cited by 189
The Role of Strain Variation in Murine Bleomycin-lnduced Pulmonary Fibrosis 1, 2
Schrier, D. J., Kunkel, R. G., & Phan, S. H. (1983) · American Review of Respiratory Disease · doi:10.1164/arrd.1983.127.1.63 · Cited by 186
Kolodsick, J. E., Toews, G. B., Jakubzick, C., Hogaboam, C., Moore, T. A., McKenzie, A., Wilke, C. A., Chrisman, C. J., & Moore, B. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4068 · Cited by 185
Self-citationExpression of TNF and the Necessity of TNF Receptors in Bleomycin-Induced Lung Injury in Mice
Ortiz, L. A., Lasky, J., Hamilton, R. F., Holian, A., Hoyle, G. W., Banks, W., Peschon, J. J., Brody, A. R., Lungarella, G., & Friedman, M. (1998) · Experimental Lung Research · doi:10.3109/01902149809099592 · Cited by 181
Radiation-Induced Pulmonary Fibrosis: Examination of Chemokine and Chemokine Receptor Families
Johnston, C. J., Williams, J. P., Okunieff, P., & Finkelstein, J. N. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)157[0256:ripfeo]2.0.co;2 · Cited by 178
Semaphorin 7A plays a critical role in TGF-β1–induced pulmonary fibrosis
Kang, H.-R., Lee, C. G., Homer, R. J., & Elias, J. A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061273 · Cited by 176
Lawson, W. E., Polosukhin, V. V., Stathopoulos, G. T., Zoia, O., Han, W., Lane, K. B., Li, B., Donnelly, E. F., Holburn, G. E., Lewis, K. G., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61214-x · Cited by 174
Lakatos, H. F., Burgess, H. A., Thatcher, T. H., Redonnet, M. R., Hernady, E., Williams, J. P., & Sime, P. J. (2006) · Experimental Lung Research · doi:10.1080/01902140600817465 · Cited by 174
Snider, G. L., Celli, B. R., Goldstein, R. H., O’Brien, J. J., & Lucey, E. C. (1978) · PubMed · doi:10.1164/arrd.1978.117.2.289 · Cited by 166
Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis.
Zhang, K., Gharaee-Kermani, M., Jones, M. L., Warren, J. S., & Phan, S. H. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4733 · Cited by 165
Olman, M. A., Mackman, N., Gladson, C. L., Moser, K. M., & Loskutoff, D. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118201 · Cited by 164
Epperly, M. W., Bray, J. A., Krager, S., Berry, L. M., Gooding, W. E., Engelhardt, J. F., Zwacka, R. M., Travis, E. L., & Greenberger, J. S. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00355-1 · Cited by 158
Gender-Based Differences in Bleomycin-Induced Pulmonary Fibrosis
Gharaee‐Kermani, M., Hatano, K., Nozaki, Y., & Phan, S. H. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62470-4 · Cited by 148
High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis.
Harrison, J. H., & Lazo, J. S. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39287-6 · Cited by 148
Xing, Z., Tremblay, G. M., Sime, P. J., & Gauldie, J. (1997) · Europe PMC (PubMed Central) · Cited by 139
Phan, S. H., Thrall, R. S., & Ward, P. A. (1980) · American Review of Respiratory Disease · doi:10.1164/arrd.1980.121.3.501 · Cited by 137
Fujita, M., Shannon, J. M., Morikawa, O., Gauldie, J., Hara, N., & Mason, R. J. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0046oc · Cited by 135
Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice
Inoshima, I., Kuwano, K., Hamada, N., Hagimoto, N., Yoshimi, M., Maeyama, T., Takeshita, A., Kitamoto, S., Egashira, K., & Hara, N. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00167.2003 · Cited by 131
Pulmonary Toxicity of Bleomycin
Adamson, I. Y. R. (1976) · Environmental Health Perspectives · doi:10.1289/ehp.7616119 · Cited by 128
STARCHER, B. C., Kuhn, C., & Overton, J. (1978) · PubMed · doi:10.1164/arrd.1978.117.2.299 · Cited by 123
Barbarin, V., Xing, Z., Delos, M., Lison, D., & Huaux, F. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00329.2004 · Cited by 122
Sharplin, J., & Franko, A. J. (1989) · Radiation Research · doi:10.2307/3577363 · Cited by 120
Haston, C. K., & Travis, E. L. (1997) · PubMed · Cited by 119
TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury.
Smith, R. E., Strieter, R. M., Phan, S. H., Lukacs, N. W., & Kunkel, S. L. (1998) · PubMed · Cited by 118
T cell independence of bleomycin-induced pulmonary fibrosis
Helene, M., Lake-Bullock, V, Zhu, J., Hao, H., Cohen, D. A., & Kaplan, A. M. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.2.187 · Cited by 117
The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis
Barbarin, V., Nihoul, A., Misson, P., Arras, M., Delos, M., Leclercq, I. A., Lison, D., & Huaux, F. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-112 · Cited by 116
Transforming growth factor-β: A mediator of cell regulation in acute respiratory distress syndrome
Dhainaut, J.-F., Charpentier, J., & Chiche, J. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000057901.92381.75 · Cited by 112
TNF and IL-6 mediate MIP-1α expression in bleomycin-induced lung injury
Smith, R. E., Strieter, R. M., Phan, S. H., Lukacs, N. W., & Kunkel, S. L. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.4.528 · Cited by 112
Lung infection with γ-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice
Mora, A. L., Woods, C. R., García, A., Xu, J., Rojas, M. M., Speck, S. H., Roman, J., Brigham, K. L., & Stecenko, A. A. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00007.2005 · Cited by 105
Sebti, S. M., Mignano, J. E., Jani, J. P., Srimatkandada, S., & Lazo, J. S. (1989) · Biochemistry · doi:10.1021/bi00442a003 · Cited by 103
Chemistry and mechanism of action of bleomycin.
Umezawa, H. (1974) · PubMed · Cited by 102
Persistent overexpression of interleukin-1beta and tumor necrosis factor-alpha in murine silicosis.
Davis, G. S., Pfeiffer, L., & Hemenway, D. R. (1998) · PubMed · Cited by 100
Repression of Bleomycin-Induced Pneumopathy by TNF
Kuroki, M., Noguchi, Y., Shimono, M., Tomono, K., Tashiro, T., Obata, Y., Nakayama, E., & Kohno, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.567 · Cited by 95
Sisson, T. H., Hanson, K. E., Subbotina, N., Patwardhan, A., Hattori, N., & Simon, R. H. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00049.2002 · Cited by 93
Pierce, E. M., Carpenter, K. J., Jakubzick, C., Kunkel, S. L., Flaherty, K. R., Martínez, F. J., & Hogaboam, C. M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060649 · Cited by 92
Self-citationJohnston, C. J., Wright, T. W., Rubin, P., & Finkelstein, J. N. (1998) · Experimental Lung Research · doi:10.3109/01902149809041538 · Cited by 88
Christensen, P. J., Goodman, R. E., Pastoriza, L., Moore, B. B., & Toews, G. B. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65493-4 · Cited by 87
Self-citationPulmonary toxicity of antitumor agents
Muggia, F. M., Louie, A. C., & Sikic, B. I. (1983) · Cancer Treatment Reviews · doi:10.1016/0305-7372(83)90012-9 · Cited by 84
Eicosanoids: mediators and therapeutic targets in fibrotic lung disease
Charbeneau, R. P., & Peters-Golden, M. L. (2005) · Clinical Science · doi:10.1042/cs20050012 · Cited by 79
Chronic Interstitial Pulmonary Fibrosis Produced in Hamsters by Endotracheal Bleomycin
Snider, G. L., Celli, B. R., Goldstein, R. H., et al. (2015) · American Review of Respiratory Disease · Cited by 75
Goldstein, R. H., Lucey, E. C., Franzblau, C., & Snider, G. L. (1979) · PubMed · doi:10.1164/arrd.1979.120.1.67 · Cited by 75
Lok, S., Haider, Y., Howell, D. C. J., Stewart, J. P., Hasleton, P. S., & Egan, J. J. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00272902 · Cited by 73
Readministration of helper-dependent adenovirus to mouse lung
Koehler, D. R., Martin, B., Corey, M. L., Palmer, D. J., Ng, P., Tanswell, A. K., & Hu, J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302712 · Cited by 60
Mechanisms and Mediators of Pulmonary Fibrosis
Keane, M. P., Strieter, R. M., & Belperio, J. A. (2005) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v25.i6.10 · Cited by 54
Integrin-Mediated Activation of Transforming Growth Factor-β1 in Pulmonary Fibrosis
Sheppard, D. (2001) · CHEST Journal · doi:10.1378/chest.120.1_suppl.s49 · Cited by 47
Role of Urokinase in the Fibrogenic Response of the Lung to Mineral Particles
Lardot, C., HUAUX, F. A., Broeckaert, F., Declerck, P. J., Delos, M., Fubini, B., & Lison, D. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9707052 · Cited by 47
A novel model for human interstitial lung disease: Hapten‐driven lung fibrosis in rodents
Roberts, S., Howie, S., Wallace, W. A., Brown, D. M., Lamb, D., Ramage, E., & Donaldson, K. (1995) · The Journal of Pathology · doi:10.1002/path.1711760313 · Cited by 47
Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques
Fischer, A. C., Beck, S. E., Smith, C. I., Laube, B. L., Askin, F. B., Guggino, S. E., Adams, R. J., Flotte, T. R., & Guggino, W. B. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.08.015 · Cited by 46
McDonald, S. A., Rubin, P., Chang, A. Y., Penney, D. P., Finkelstein, J. N., Grossberg, S. E., Feins, R. H., & Gregory, P. K. (1993) · Radiotherapy and Oncology · doi:10.1016/0167-8140(93)90262-7 · Cited by 42
Lung collagen: definition, diversity and development.
Rg, C. (1974) · PubMed · Cited by 42
Franko, A. J., Sharplin, J., Ward, W. F., & Taylor, J. M. (1996) · Radiation Research · doi:10.2307/3579397 · Cited by 40
Transgenic models for the study of lung biology and disease
Ho, Y.-S. (1994) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1994.266.4.l319 · Cited by 30
Genetic linkage analysis of pulmonary fibrotic response to silica in mice
Ohtsuka, Y., Wang, X.-T., Saito, J., Ishida, T., & Munakata, M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00132505 · Cited by 28
Phan, S. H., Armstrong, G. L., Sulavik, M. C., Schrier, D. J., Johnson, K. J., & Ward, P. A. (1983) · CHEST Journal · doi:10.1378/chest.83.5_supplement.44s · Cited by 26
Misson, P., Brombacher, F., Delos, M., Lison, D., & Huaux, F. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00503.2005 · Cited by 24
Cited by
Animal models of acute lung injury
Matute-Bello, G., Frevert, C. W., & Martin, T. R. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00010.2008 · Cited by 1,728
Integrating mechanisms of pulmonary fibrosis
Wynn, T. A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110551 · Cited by 1,274
miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
Liu, G., Friggeri, A., Yang, Y., Milosevic, J., Ding, Q., Thannickal, V. J., Kaminski, N., & Abraham, E. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100035 · Cited by 935
“A miRNA array assay was performed on RNA isolated from the lungs of mice that had been given intratracheal PBS or bleomycin for 1 or 2 wk, a well-characterized model of lung fibrosis (Moore and Hogaboam, 2008).”
BackgroundMethodInfluentialPathogenesis of Idiopathic Pulmonary Fibrosis
Wolters, P. J., Collard, H. R., & Jones, K. D. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104706 · Cited by 862
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Moss, B. J., Ryter, S. W., & Rosas, I. O. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-030240 · Cited by 821
Metadata
- Authors
- Moore, B. B., & Hogaboam, C. M.
- Venue
- American Journal of Physiology-Lung Cellular and Molecular Physiology
- Publisher
- American Physiological Society
- Published
- 2008-02
- Volume
- 294
- Issue
- 2
- Pages
- L152-L160
- ISSN
- 1040-0605 (ISSN-L)
- 1522-1504
- OpenAlex
- W2167211373
- Cited by
- 796
- References
- 88
- FWCI
- 20.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.